{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:07:18Z","timestamp":1783937238997,"version":"3.55.0"},"reference-count":135,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It has been more than 60 years since the development of Rome criteria for ankylosing spondylitis (AS). These criteria wonderfully delineated the clinical pictures of AS, and since then, tremendous works has paved the way for the study and management of AS patients. However, their low sensitivity, specificity and the potential for a delay diagnosis remain major problems of these criteria. Over the past six decades, new classification criteria had been developed to address these issues. As is often the case, new solutions bring new challenges. Avoiding over-diagnosis and over-treatment become a crucial contemporary issue. Hopefully, new modifications of classification criteria are on their way to better defining and treating AS patients.<\/jats:p>","DOI":"10.1515\/rir-2026-0025","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:10:36Z","timestamp":1783933836000},"page":"63-73","source":"Crossref","is-referenced-by-count":0,"title":["The 60\n                    <sup>+<\/sup>\n                    year journey of ankylosing spondylitis from Rome criteria to today"],"prefix":"10.1515","volume":"7","author":[{"given":"Chenching","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kaohsiung Medical University Hospital , Taiwan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2777-4298","authenticated-orcid":false,"given":"Wenchan","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaohsiung Medical University Hospital , Taiwan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2026071309102994797_j_rir-2026-0025_ref_001","doi-asserted-by":"crossref","unstructured":"Spencer DG, Sturrock RD, Buchanan WW. Ankylosing spondylitis: Yesterday and today. Med Hist. 1980;24:60\u201369.","DOI":"10.1017\/S0025727300039788"},{"key":"2026071309102994797_j_rir-2026-0025_ref_002","doi-asserted-by":"crossref","unstructured":"Mau W, Zeidler H, Mau R, et al. Outcome of possible ankylosing spondylitis in a 10 years\u2019 follow-up study. Clin Rheumatol. 1987;6:60\u201366.","DOI":"10.1007\/BF02203386"},{"key":"2026071309102994797_j_rir-2026-0025_ref_003","doi-asserted-by":"crossref","unstructured":"Bennett AN, McGonagle D, O\u2019Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 2008;58:3413\u20133418.","DOI":"10.1002\/art.24024"},{"key":"2026071309102994797_j_rir-2026-0025_ref_004","doi-asserted-by":"crossref","unstructured":"Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994;37:1039\u20131045.","DOI":"10.1002\/art.1780370709"},{"key":"2026071309102994797_j_rir-2026-0025_ref_005","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, van der Heijde D, Landewe\u00b4 R, et al. The development of Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u2013 783.","DOI":"10.1136\/ard.2009.108233"},{"key":"2026071309102994797_j_rir-2026-0025_ref_006","doi-asserted-by":"crossref","unstructured":"van der Heijde, Molto A, Ramiro S, et al. Goodbye to the term \u2018ankylosing spondylitis\u2019, hello \u2018axial spondyloarthritis\u2019: time to embrace the ASAS-defined nomenclature Ann Rheum Dis. 2024;83:547\u2013549.","DOI":"10.1136\/ard-2023-225185"},{"key":"2026071309102994797_j_rir-2026-0025_ref_007","unstructured":"Wright V, Moll JMH. Seronegative polyarthritis. North Holland Publishing Co.; 1976: 81\u201384."},{"key":"2026071309102994797_j_rir-2026-0025_ref_008","doi-asserted-by":"crossref","unstructured":"Marketos SG, Skiadas P. Hippocrates. The father of spine surgery. Spine (Phila Pa 1976). 1999;24:1381\u20131387.","DOI":"10.1097\/00007632-199907010-00018"},{"key":"2026071309102994797_j_rir-2026-0025_ref_009","doi-asserted-by":"crossref","unstructured":"Rufferand MA, Rietti A. On osseus lesions in Ancient Egyptians. J Path Bact. 1912;16:439\u2013465.","DOI":"10.1002\/path.1700160133"},{"key":"2026071309102994797_j_rir-2026-0025_ref_010","unstructured":"Smith GE, Jones FW. Report on human remains. The Archaeological Survey of Nubia 1907\u20131908. Cairo: National Printing Department; 1910;2:273\u2013277."},{"key":"2026071309102994797_j_rir-2026-0025_ref_011","doi-asserted-by":"crossref","unstructured":"Connor B. An extract of a letter from Bernard Connor, M.D. to Sir Charles Walgrave. Philosophical Transactions of the Royal Society of London. 1695\u20131697;19:21.","DOI":"10.1098\/rstl.1695.0005"},{"key":"2026071309102994797_j_rir-2026-0025_ref_012","unstructured":"Bourke J.B. Review of palaeopathology of arthritic diseases. In D. Brothwell and A. T. Sandison (eds), Diseases ofantiquity, Springfield; 1967: 357\u2013360."},{"key":"2026071309102994797_j_rir-2026-0025_ref_013","doi-asserted-by":"crossref","unstructured":"Bourke JB. The palaeopathology ofthe vertebral column in Ancient Egypt and Nubia. Med Hist.1971;15:363\u2013375.","DOI":"10.1017\/S0025727300016914"},{"key":"2026071309102994797_j_rir-2026-0025_ref_014","unstructured":"Petrie WMF. Diaspolis Parva (The cemeteries of Abadiyeh and Hu). London: Special Extra Publication of the Egypt Exploration Fund; 1901."},{"key":"2026071309102994797_j_rir-2026-0025_ref_015","doi-asserted-by":"crossref","unstructured":"Feldtkeller E, Lemmel E-M, Russell AS. Ankylosing spondylitis in the pharaohs of ancient Egypt. Rheumatol Int. 2003;23:1\u20135.","DOI":"10.1007\/s00296-002-0242-7"},{"key":"2026071309102994797_j_rir-2026-0025_ref_016","doi-asserted-by":"crossref","unstructured":"Smyth CJ, Freyberg RH, Lampe I. Roentgen therapy for rheumatoid arthritis of the spine. J Amer Med Ass. 1941;117:826\u2013 831.","DOI":"10.1001\/jama.1941.02820360008004"},{"key":"2026071309102994797_j_rir-2026-0025_ref_017","doi-asserted-by":"crossref","unstructured":"Hench PS, Bauer W, Boland E, et al. Rheumatism and arthritis. Review of the American and English literature for 1940. Ann Intern Med. 1941;15:1002\u20131108.","DOI":"10.7326\/0003-4819-15-6-1002"},{"key":"2026071309102994797_j_rir-2026-0025_ref_018","doi-asserted-by":"crossref","unstructured":"Polley HF, Slocumb CH. Rheumatoid spondylitis: a study of 1,035 cases. Ann Intern Med. 1947;26:240-249.","DOI":"10.7326\/0003-4819-26-2-240"},{"key":"2026071309102994797_j_rir-2026-0025_ref_019","doi-asserted-by":"crossref","unstructured":"Forbech V. Do the mutual features dominate the separating features in rheumatoid arthritis and rheumatoid spondylitis? Acta Med Scand. 1958;341:43\u201346.","DOI":"10.1111\/j.0954-6820.1958.tb19087.x"},{"key":"2026071309102994797_j_rir-2026-0025_ref_020","doi-asserted-by":"crossref","unstructured":"Hart FD, Maclagan NF. Ankylosing spondylitis. A review of 184 cases. Ann Rheum Dis. 1955;14:77\u201383.","DOI":"10.1136\/ard.14.1.77"},{"key":"2026071309102994797_j_rir-2026-0025_ref_021","doi-asserted-by":"crossref","unstructured":"de Blecourt JJ, Polman A, de Blecourt-Meindersma T. Hereditary factors in rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis. 1961;20:215\u2013220.","DOI":"10.1136\/ard.20.3.215"},{"key":"2026071309102994797_j_rir-2026-0025_ref_022","doi-asserted-by":"crossref","unstructured":"Waaler E. On the occurrence of a factor in human serum activating specific agglutination of sheep blood corpuscles. Acta Path Microbiol Scand. 1940;17:172\u2013188.","DOI":"10.1111\/j.1699-0463.1940.tb01475.x"},{"key":"2026071309102994797_j_rir-2026-0025_ref_023","doi-asserted-by":"crossref","unstructured":"Rose HM, Ragan C, Pearce E, et al. \u2018Differential agglutination of normal and sensitized sheep erythrocytes by sera ofpatients with rheumatoid arthritis. Proc Soc Exp Biol Med. 1948;68:1\u20136.","DOI":"10.3181\/00379727-68-16375"},{"key":"2026071309102994797_j_rir-2026-0025_ref_024","unstructured":"Krebs W. Das R\u00f6ntgenbild des Beckens bei der Bechterew\u2019schen Krankheit. Fortschr. Geb. R\u00f6ntgenstr 1934;50:537."},{"key":"2026071309102994797_j_rir-2026-0025_ref_025","doi-asserted-by":"crossref","unstructured":"Krebs W, Vontz O. Entstehung und Verlauf der Spondylitis ankylopoetica (Bechterew). Dtsch Med Wochenschr. 1934;60:100.","DOI":"10.1055\/s-0028-1129763"},{"key":"2026071309102994797_j_rir-2026-0025_ref_026","unstructured":"The Epidemiology of Chronic Rheumatism. Kellgren JH, Jeffrey MR, Ball J. (eds). Oxford; 1963;1:326."},{"key":"2026071309102994797_j_rir-2026-0025_ref_027","unstructured":"Bennett PH, Wood PH, editors. Population Studies of the Rheumatic Diseases: Proceedings of the 3rd International Symposium, New York, June 5\u201310, 1966. Amsterdam, New York: Excerpta Medica Foundation; 1968."},{"key":"2026071309102994797_j_rir-2026-0025_ref_028","doi-asserted-by":"crossref","unstructured":"Calin A, Porta J, Fries JF, et al. Clinical history as a screen test for ankylosing spondylitis. JAMA. 1977;237:2613\u20132614.","DOI":"10.1001\/jama.1977.03270510035017"},{"key":"2026071309102994797_j_rir-2026-0025_ref_029","doi-asserted-by":"crossref","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u2013368.","DOI":"10.1002\/art.1780270401"},{"key":"2026071309102994797_j_rir-2026-0025_ref_030","doi-asserted-by":"crossref","unstructured":"Goei HS, Steven MM, Van Der Linden SM, et al. Evaluation of diagnostic criteria for ankylosing spondylitis: A comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Rheumatology. 1985;24:242\u2013249.","DOI":"10.1093\/rheumatology\/24.3.242"},{"key":"2026071309102994797_j_rir-2026-0025_ref_031","doi-asserted-by":"crossref","unstructured":"Schlosstein I, Terasaki PI, Bluestone R, et al. High association of an HLA antigen, W27, with ankylosing spondylitis. New Eng J Med. 1973;288:704\u2013706.","DOI":"10.1056\/NEJM197304052881403"},{"key":"2026071309102994797_j_rir-2026-0025_ref_032","doi-asserted-by":"crossref","unstructured":"Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HLA-B27. Lancet. 1973;301:904\u2013907.","DOI":"10.1016\/S0140-6736(73)91360-3"},{"key":"2026071309102994797_j_rir-2026-0025_ref_033","doi-asserted-by":"crossref","unstructured":"Garrett TP, Saper MA, Bjorkman PJ, et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 1989;342:692\u2013696.","DOI":"10.1038\/342692a0"},{"key":"2026071309102994797_j_rir-2026-0025_ref_034","doi-asserted-by":"crossref","unstructured":"Colber RA, Rowland-Jones SL, McMicheal AJ, et al. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. Proc Natl Acad Sci U S A. 1993;90:6879\u20136883.","DOI":"10.1073\/pnas.90.14.6879"},{"key":"2026071309102994797_j_rir-2026-0025_ref_035","doi-asserted-by":"crossref","unstructured":"Yamaguchi A, Tsuchiya N, Misui H, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum. 1995;38:1672\u20131677.","DOI":"10.1002\/art.1780381120"},{"key":"2026071309102994797_j_rir-2026-0025_ref_036","doi-asserted-by":"crossref","unstructured":"Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63:1099\u20131112.","DOI":"10.1016\/0092-8674(90)90512-D"},{"key":"2026071309102994797_j_rir-2026-0025_ref_037","doi-asserted-by":"crossref","unstructured":"Taurog JD, Hammer RE. Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clin Rheumatol. 1996;15 Suppl 1:22\u201327","DOI":"10.1007\/BF03342640"},{"key":"2026071309102994797_j_rir-2026-0025_ref_038","doi-asserted-by":"crossref","unstructured":"Taurog JD. Arthritis in HLA-B27 transgenic animals. Am J Med Sci. 1998;316:250\u2013256.","DOI":"10.1097\/00000441-199810000-00005"},{"key":"2026071309102994797_j_rir-2026-0025_ref_039","doi-asserted-by":"crossref","unstructured":"Ansalone C, Utriainen L, Milling S, et al. Role of Gut Inflammation in Altering the Monocyte Compartment and Its Osteoclastogenic Potential in HLA-B27-Transgenic Rats. Arthritis Rheumatol. 2017;69:1807\u20131815","DOI":"10.1002\/art.40154"},{"key":"2026071309102994797_j_rir-2026-0025_ref_040","doi-asserted-by":"crossref","unstructured":"Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359\u20132364.","DOI":"10.1084\/jem.180.6.2359"},{"key":"2026071309102994797_j_rir-2026-0025_ref_041","doi-asserted-by":"crossref","unstructured":"Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990;11:137\u2013142.","DOI":"10.1016\/0167-5699(90)90051-A"},{"key":"2026071309102994797_j_rir-2026-0025_ref_042","doi-asserted-by":"crossref","unstructured":"Sesma L, Montserrat V, Lamas JR, et al. The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. J Biol Chem. 2002;277:16744\u201316779.","DOI":"10.1074\/jbc.M200371200"},{"key":"2026071309102994797_j_rir-2026-0025_ref_043","doi-asserted-by":"crossref","unstructured":"Huppertz HI, Heesemann J. Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27. Ann Rheum Dis. 1997;56:671\u2013676.","DOI":"10.1136\/ard.56.11.671"},{"key":"2026071309102994797_j_rir-2026-0025_ref_044","doi-asserted-by":"crossref","unstructured":"Allen RL, O\u2019Callaghan CA, McMichael AJ, et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999;162:5045\u20135048","DOI":"10.4049\/jimmunol.162.9.5045"},{"key":"2026071309102994797_j_rir-2026-0025_ref_045","unstructured":"Tsai WC, Chen CJ, Yen JH, et al. W. Free HLA class I heavy chain-carrying monocytes--a potential role in the pathogenesis of spondyloarthropathies J Rheumatol. 2002;29:966\u2013972"},{"key":"2026071309102994797_j_rir-2026-0025_ref_046","doi-asserted-by":"crossref","unstructured":"David M E, Spencer CCA, Jennifer J.P, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43:761\u2013767.","DOI":"10.1038\/ng0911-919a"},{"key":"2026071309102994797_j_rir-2026-0025_ref_047","doi-asserted-by":"crossref","unstructured":"Jurgen B, M\u00e4rker-Hermann E, Rudwaleit M, et al. HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis Ann Rheum Dis. 2024;83:1406\u20131408.","DOI":"10.1136\/ard-2024-225661"},{"key":"2026071309102994797_j_rir-2026-0025_ref_048","doi-asserted-by":"crossref","unstructured":"Liu CH, Raj S, Chen CH, et al. HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis. J Clin Invest. 2019;129:5357\u2013 5373.","DOI":"10.1172\/JCI125212"},{"key":"2026071309102994797_j_rir-2026-0025_ref_049","doi-asserted-by":"crossref","unstructured":"van der Linden SM, Valkenburg HA, de Jongh BM, et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 1984;27:241\u2013249.","DOI":"10.1002\/art.1780270301"},{"key":"2026071309102994797_j_rir-2026-0025_ref_050","doi-asserted-by":"crossref","unstructured":"van der Linden SM, Khan MA, Li Z, et al. Factors predicting axial spondyloarthritis among first-degree relatives of probands with ankylosing spondylitis: a family study spanning 35 years. Ann Rheum Dis. 2022;81:831\u2013837.","DOI":"10.1136\/annrheumdis-2021-222083"},{"key":"2026071309102994797_j_rir-2026-0025_ref_051","doi-asserted-by":"crossref","unstructured":"van der Linden SM, Khan MA, Li Z, et al. Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study. RMD Open. 2022;8:e002208.","DOI":"10.1136\/rmdopen-2022-002208"},{"key":"2026071309102994797_j_rir-2026-0025_ref_052","unstructured":"Gofton JP, Chalmers A, Price GE,et al. HL-A 27 and ankylosing spondylitis in B.C. Indians. J Rheumatol. 1984;11:572\u2013573"},{"key":"2026071309102994797_j_rir-2026-0025_ref_053","doi-asserted-by":"crossref","unstructured":"Mathieu A, Cauli A, Fiorillo MT, et al. HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis Autoimmun Rev. 2008;7:398\u2013403.","DOI":"10.1016\/j.autrev.2008.03.013"},{"key":"2026071309102994797_j_rir-2026-0025_ref_054","doi-asserted-by":"crossref","unstructured":"Yang KL, Chen IH, Hsiao CK, et al. Polymorphism of HLA-B27 in Taiwanese Chinese. Tissue Antigens. 2004;63:476\u2013479.","DOI":"10.1111\/j.0001-2815.2004.00197.x"},{"key":"2026071309102994797_j_rir-2026-0025_ref_055","unstructured":"Nasution AR, Mardjuadi A, Kunmartini S, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol. 1997;24:1111\u20131114."},{"key":"2026071309102994797_j_rir-2026-0025_ref_056","doi-asserted-by":"crossref","unstructured":"Ben Radhia K, Ayed-Jendoubi S, Sfar I, et al. Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine. 2008;75:172\u2013175.","DOI":"10.1016\/j.jbspin.2007.05.020"},{"key":"2026071309102994797_j_rir-2026-0025_ref_057","doi-asserted-by":"crossref","unstructured":"Khan MA, Yong SB, Wei CC. Ankylosing spondylitis: History, epidemiology, and HLA-B27. Int J Rheum Dis. 2023;26:413\u2013414.","DOI":"10.1111\/1756-185X.14547"},{"key":"2026071309102994797_j_rir-2026-0025_ref_058","doi-asserted-by":"crossref","unstructured":"Jing YY, Li DM, Liu N, et al. Recognition of the Novel HLA-A*02:07:01:07 Allele Through Third-Generation HLA-Targeted Sequencing Technology. HLA. 2025;105:e70120.","DOI":"10.1111\/tan.70120"},{"key":"2026071309102994797_j_rir-2026-0025_ref_059","doi-asserted-by":"crossref","unstructured":"Braun J, Sieper J. Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD Open. 2023;9:e003102.","DOI":"10.1136\/rmdopen-2023-003102"},{"key":"2026071309102994797_j_rir-2026-0025_ref_060","doi-asserted-by":"crossref","unstructured":"Wright V, Reed WB. The link between Reiter\u2019s syndrome and psoriatic arthritis. Ann Rheum Dis. 1964;23:12\u201321.","DOI":"10.1136\/ard.23.1.12"},{"key":"2026071309102994797_j_rir-2026-0025_ref_061","doi-asserted-by":"crossref","unstructured":"Wright V. Psoriasis and arthritis. Ann of Rheum Dis. 1956;15:348\u2013356.","DOI":"10.1136\/ard.15.4.348"},{"key":"2026071309102994797_j_rir-2026-0025_ref_062","doi-asserted-by":"crossref","unstructured":"Wright V. Psoriatic arthritis: a comparative study of rheumatoid arthritis and arthritis associated with psoriasis. Ann of Rheum Dis. 1961;20:123\u2013132.","DOI":"10.1136\/ard.20.2.123"},{"key":"2026071309102994797_j_rir-2026-0025_ref_063","doi-asserted-by":"crossref","unstructured":"Bywaters EGL, Dixon A St J. Paravertebral ossification in psoriatic arthritis. Ann Rheum Dis. 1965;24:313\u2013331.","DOI":"10.1136\/ard.24.4.313"},{"key":"2026071309102994797_j_rir-2026-0025_ref_064","doi-asserted-by":"crossref","unstructured":"Jaji\u0107 I. Radiological changes in sacroiliac joints and spine of patients with psoriatic arthritis and psoriasis. Ann of Rheum Dis. 1968;27:1\u20136.","DOI":"10.1136\/ard.27.1.1"},{"key":"2026071309102994797_j_rir-2026-0025_ref_065","unstructured":"Copeman WSC. Introductory note on the nomenclature and classification of the rheumatic diseases. Textbook of the Rheumatic Diseases, 4th Ed (ed WSC Copeman) Livingstone; 1969: 12."},{"key":"2026071309102994797_j_rir-2026-0025_ref_066","unstructured":"Acheson ED. An association between ulcerative colitis regional enteritis and ankylosing spondylitis. Q J Med. 1960;29:489\u2013 499."},{"key":"2026071309102994797_j_rir-2026-0025_ref_067","doi-asserted-by":"crossref","unstructured":"Mcbride JA, King MJ, Baikie AG, et al. Ankylosing spondylitis and chronic inflammatory diseases of the intestines. Br J Med. 1963;2:483\u2013486.","DOI":"10.1136\/bmj.2.5355.483"},{"key":"2026071309102994797_j_rir-2026-0025_ref_068","doi-asserted-by":"crossref","unstructured":"Ansell BM, Wigley RA. Arthritic manifestations in regional enteritis. Ann Rheum Dis. 1964;23:64\u201372.","DOI":"10.1136\/ard.23.1.64"},{"key":"2026071309102994797_j_rir-2026-0025_ref_069","doi-asserted-by":"crossref","unstructured":"Moll JMH, Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973;32:181\u2013201.","DOI":"10.1136\/ard.32.3.181"},{"key":"2026071309102994797_j_rir-2026-0025_ref_070","doi-asserted-by":"crossref","unstructured":"Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133\u2013 144","DOI":"10.7326\/0003-4819-59-2-133"},{"key":"2026071309102994797_j_rir-2026-0025_ref_071","doi-asserted-by":"crossref","unstructured":"Hammer B, Ashurst P, Naish J Diseases associated with ulcerative colitis and Crohn\u2019s disease. Gut. 1968;9:17\u201321.","DOI":"10.1136\/gut.9.1.17"},{"key":"2026071309102994797_j_rir-2026-0025_ref_072","doi-asserted-by":"crossref","unstructured":"Moll JMH. \u201cThe Leeds ideas\u201d: An historic account of the spondarthritis concept. Reumatismo. 2007;59:13\u201318.","DOI":"10.4081\/reumatismo.2007.1s.13"},{"key":"2026071309102994797_j_rir-2026-0025_ref_073","doi-asserted-by":"crossref","unstructured":"Moll JMH, Haslock I, Macrae IF, et al. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter\u2019s disease, the intestinal arthropathies, and Behcet\u2019s syndrome. Medicine (Baltimore). 1974;53:343\u2013364.","DOI":"10.1097\/00005792-197409000-00002"},{"key":"2026071309102994797_j_rir-2026-0025_ref_074","doi-asserted-by":"crossref","unstructured":"Calin A. Seronegative spondyloarthritides. Med Clin North Am. 1986;70:323\u2013336.","DOI":"10.1016\/S0025-7125(16)30956-7"},{"key":"2026071309102994797_j_rir-2026-0025_ref_075","doi-asserted-by":"crossref","unstructured":"Khan M, van der Linden SM. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum. 1990;20:107\u2013113.","DOI":"10.1016\/0049-0172(90)90023-9"},{"key":"2026071309102994797_j_rir-2026-0025_ref_076","doi-asserted-by":"crossref","unstructured":"Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218\u20131227.","DOI":"10.1002\/art.1780341003"},{"key":"2026071309102994797_j_rir-2026-0025_ref_077","unstructured":"Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic. 1990;57:85\u201389."},{"key":"2026071309102994797_j_rir-2026-0025_ref_078","doi-asserted-by":"crossref","unstructured":"Chung HY, Lau CS, Wu KP, et al. Comparison of performance of the Assessment ofSpondyloArthritis International Society, the European Spondyloarthropathy Study Group and themodified New York criteria in a cohort of Chinese patients with spondyloarthritis. Clin Rheumatol. 2011;30:947\u2013953.","DOI":"10.1007\/s10067-011-1693-6"},{"key":"2026071309102994797_j_rir-2026-0025_ref_079","unstructured":"Amor B, Dougados M, Listrat V, et al. Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG). A cross-sectional analysis of 2,228 patients. Ann MedInterne (Paris). 1991;142:85."},{"key":"2026071309102994797_j_rir-2026-0025_ref_080","doi-asserted-by":"crossref","unstructured":"Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011;2:107\u2013115.","DOI":"10.5312\/wjo.v2.i12.107"},{"key":"2026071309102994797_j_rir-2026-0025_ref_081","unstructured":"Zhao L, Liao Z, Yu D, Li T, Gu J. Evaluation of the European Spondyloarthropathy Study Group (ESSG) classification criteria in a Chinese population. Clin Exp Rheum. 2005;23:397\u2013399."},{"key":"2026071309102994797_j_rir-2026-0025_ref_082","unstructured":"Collantes-Estevez E, Cisnal del Mazo A, Mu\u00f1oz-Gomariz E. Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study Group J Rheumatol. 1995;22:246\u2013251."},{"key":"2026071309102994797_j_rir-2026-0025_ref_083","unstructured":"Ert\u00fcrk M, Alaca R, Tosun E, et al. Evaluation of the Amor and ESSG classification criteria forspondylarthropathies in a Turkish population. Rev Rhum Engl Ed. 1997;64:293\u2013300."},{"key":"2026071309102994797_j_rir-2026-0025_ref_084","doi-asserted-by":"crossref","unstructured":"Collantes E, Veroz R, Escudero A, et al. Can some cases of \u2018possible\u2019 spondyloarthropathy be classified as \u2018definite\u2019or \u2018undifferentiated\u2019 spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine. 2000;67:516\u2013520.","DOI":"10.1016\/S1297-319X(00)00201-3"},{"key":"2026071309102994797_j_rir-2026-0025_ref_085","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52:1000\u20131008.","DOI":"10.1002\/art.20990"},{"key":"2026071309102994797_j_rir-2026-0025_ref_086","doi-asserted-by":"crossref","unstructured":"Murphey MD, Wetzel LH, Bramble JM, et al. Sacroiliitis: MR imaging findings. Radiology 1991;180:239\u2013244.","DOI":"10.1148\/radiology.180.1.2052702"},{"key":"2026071309102994797_j_rir-2026-0025_ref_087","unstructured":"Hanly JG, Mitchell MJ, Barnes DC, et al. Early recognition of sacroiliitis by magnetic resonance imaging and single photon emissioncomputed tomography. J Rheumatol. 1994;21:2088\u2013 2095."},{"key":"2026071309102994797_j_rir-2026-0025_ref_088","doi-asserted-by":"crossref","unstructured":"Aliabadi P, Nikpoor N. Imaging evaluation of sacroiliitisRheum Dis Clin North Am. 1991;17:809\u2013812.","DOI":"10.1016\/S0889-857X(21)00123-X"},{"key":"2026071309102994797_j_rir-2026-0025_ref_089","unstructured":"Docherty P, Mitchell MJ, MacMillan L, et al. Magnetic resonance imaging in the detection of sacroiliitis. J Rheumatol. 1992;19:393\u2013401."},{"key":"2026071309102994797_j_rir-2026-0025_ref_090","unstructured":"Bollow M, Braun J, K\u00f6nig H,et al. Dynamic magnetic resonance tomography of the sacroiliac joint: diagnosis of the early stages of a sacroiliitis. Rontgenpraxis. 1994;47:70\u201377."},{"key":"2026071309102994797_j_rir-2026-0025_ref_091","doi-asserted-by":"crossref","unstructured":"Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994;37:1039\u20131045.","DOI":"10.1002\/art.1780370709"},{"key":"2026071309102994797_j_rir-2026-0025_ref_092","doi-asserted-by":"crossref","unstructured":"Egund N, Jurik A. Anatomy and histology of the sacroiliac joints. Semin Musculoskelet Radiol. 2014;18:332\u2013340.","DOI":"10.1055\/s-0034-1375574"},{"key":"2026071309102994797_j_rir-2026-0025_ref_093","doi-asserted-by":"crossref","unstructured":"Ahmadi M, Abiri F, Ahmadiani S, et al. Pregnancy-Associated Sacroiliitis following an Uncomplicated Pregnancy. Case Rep Med. 2022;2022:3596672.","DOI":"10.1155\/2022\/3596672"},{"key":"2026071309102994797_j_rir-2026-0025_ref_094","doi-asserted-by":"crossref","unstructured":"Klein MA, Winalski CS, Wax MR, et al. MR imaging of septic sacroiliitis. J Comput Assist Tomogr. 1991;15:126\u2013132.","DOI":"10.1097\/00004728-199101000-00020"},{"key":"2026071309102994797_j_rir-2026-0025_ref_095","unstructured":"Bohay DR, Gray JM. Sacroiliac joint pyarthrosis. Orthop Rev. 1993;22:817\u2013823."},{"key":"2026071309102994797_j_rir-2026-0025_ref_096","doi-asserted-by":"crossref","unstructured":"Jurik AG, Linauskas A, Kiil RM. Diagnostic features of osteitis condensans ilii by MRI\u2014a systematic literature review. Skeletal Radiol. 2025;54:423\u2013430.","DOI":"10.1007\/s00256-024-04773-6"},{"key":"2026071309102994797_j_rir-2026-0025_ref_097","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, Jurik AG, Hermann K-G A, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by theA-SAS\/OMERACT MRI group. Ann Rheum Dis. 2009;68:1520\u2013 1527.","DOI":"10.1136\/ard.2009.110767"},{"key":"2026071309102994797_j_rir-2026-0025_ref_098","doi-asserted-by":"crossref","unstructured":"Weber U, Jurik AG, Zejden A, et al. Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes: Exploring \u201cBackground Noise\u201d Toward a Data-Driven Definition of Sacroiliitis in Early Spondyloarthritis. Arthritis Rheumatol. 2018;70:736\u2013745.","DOI":"10.1002\/art.40429"},{"key":"2026071309102994797_j_rir-2026-0025_ref_099","doi-asserted-by":"crossref","unstructured":"Weber U, \u00d8stergaard M, Lambert RG, et al. Candidate lesion-based criteria for defining a positive sacroiliac joint MRI in two cohorts of patients with axial spondyloarthritis. Ann Rheum Dis. 2015;74:1976\u20131982.","DOI":"10.1136\/annrheumdis-2014-205408"},{"key":"2026071309102994797_j_rir-2026-0025_ref_100","doi-asserted-by":"crossref","unstructured":"Baraliakos X, Richter A, Feldmann D, et al. Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-basedcohort of individuals aged <45 years. Ann Rheum Dis. 2020;79:186\u2013192.","DOI":"10.1136\/annrheumdis-2019-215553"},{"key":"2026071309102994797_j_rir-2026-0025_ref_101","doi-asserted-by":"crossref","unstructured":"Maksymowych WP, Lambert RG, Baraliakos X, et al. Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility. Rheumatology (Oxford). 2021;60:4778\u20134789.","DOI":"10.1093\/rheumatology\/keab099"},{"key":"2026071309102994797_j_rir-2026-0025_ref_102","doi-asserted-by":"crossref","unstructured":"Baraliakos X , Machado PM, Bauer L, et al . Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis. RMD Open. 2024;10:e003886.","DOI":"10.1136\/rmdopen-2023-003886"},{"key":"2026071309102994797_j_rir-2026-0025_ref_103","unstructured":"de Seze S, Lequesne M. Rheumatoid spondylitis without sacroiliac changes\u2014criteria of diagnosis. Arch Interam Rheumatol. 1961;4:351\u2013362."},{"key":"2026071309102994797_j_rir-2026-0025_ref_104","doi-asserted-by":"crossref","unstructured":"Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40\u201343.","DOI":"10.1002\/art.1780280107"},{"key":"2026071309102994797_j_rir-2026-0025_ref_105","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, Landewe R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68:770\u2013776.","DOI":"10.1136\/ard.2009.108217"},{"key":"2026071309102994797_j_rir-2026-0025_ref_106","unstructured":"[106]"},{"key":"2026071309102994797_j_rir-2026-0025_ref_107","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u2013783.","DOI":"10.1136\/ard.2009.108233"},{"key":"2026071309102994797_j_rir-2026-0025_ref_108","doi-asserted-by":"crossref","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u2013 368.","DOI":"10.1002\/art.1780270401"},{"key":"2026071309102994797_j_rir-2026-0025_ref_109","doi-asserted-by":"crossref","unstructured":"Dougados M, van der Heijde D, Sieper J, et al. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2014;66:2091\u20132102.","DOI":"10.1002\/art.38721"},{"key":"2026071309102994797_j_rir-2026-0025_ref_110","unstructured":"Akkoc N, Khan MA. ASAS classification criteria for axial spondyloarthritis: a look at the unfilled part of the glass. Clin Exp Rheumatol. 2014;32 Suppl 87:14\u201315."},{"key":"2026071309102994797_j_rir-2026-0025_ref_111","doi-asserted-by":"crossref","unstructured":"Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci. 2013;345:431\u2013436.","DOI":"10.1097\/MAJ.0b013e318294457f"},{"key":"2026071309102994797_j_rir-2026-0025_ref_112","doi-asserted-by":"crossref","unstructured":"Ciurea A, Scherer A, Exer P, et al. Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Tumor necrosis factor a inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 2013;65:3096\u20133106.","DOI":"10.1002\/art.38140"},{"key":"2026071309102994797_j_rir-2026-0025_ref_113","doi-asserted-by":"crossref","unstructured":"Lo\u00b4 pez-Medina C, Ramiro S, van der Heijde D et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5:e001108.","DOI":"10.1136\/rmdopen-2019-001108"},{"key":"2026071309102994797_j_rir-2026-0025_ref_114","doi-asserted-by":"crossref","unstructured":"Weisman MH, Witter JP, Reveille JD. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009\u201310. Ann Rheum Dis. 2013;72:369\u2013373.","DOI":"10.1136\/annrheumdis-2012-201403"},{"key":"2026071309102994797_j_rir-2026-0025_ref_115","doi-asserted-by":"crossref","unstructured":"Stolwijk C, Boonen A, van Tubergen A, et al. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38:441\u2013476.","DOI":"10.1016\/j.rdc.2012.09.003"},{"key":"2026071309102994797_j_rir-2026-0025_ref_116","doi-asserted-by":"crossref","unstructured":"Baraliakos X, Listing J, von der Recke A, et al. The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features. Curr Rheumatol Rep. 2011;13:383\u2013387.","DOI":"10.1007\/s11926-011-0192-8"},{"key":"2026071309102994797_j_rir-2026-0025_ref_117","doi-asserted-by":"crossref","unstructured":"Deodhar A, Mease PJ, Reveille JD, et al. Frequency of axial spondyloarthritis diagnosis among patients seen by EU rheumatologists for evaluation of chronic back pain. Arthritis Rheumatol. 2016;68:1669\u20131676.","DOI":"10.1002\/art.39612"},{"key":"2026071309102994797_j_rir-2026-0025_ref_118","doi-asserted-by":"crossref","unstructured":"Mease PJ, Heijde DV, Karki C, et al. Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based CORRONA registry. Arthritis Care Res (Hoboken). 2018;70:1661\u20131670.","DOI":"10.1002\/acr.23534"},{"key":"2026071309102994797_j_rir-2026-0025_ref_119","doi-asserted-by":"crossref","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70:1369\u20131374.","DOI":"10.1136\/ard.2010.145995"},{"key":"2026071309102994797_j_rir-2026-0025_ref_120","doi-asserted-by":"crossref","unstructured":"Protopopov M, Poddubnyy D. Radiographic progression in non\u2011radiographic axial spondyloarthritis. Expert Rev Clin Immunol. 2018;14:525\u2013533.","DOI":"10.1080\/1744666X.2018.1477591"},{"key":"2026071309102994797_j_rir-2026-0025_ref_121","doi-asserted-by":"crossref","unstructured":"Turina MC, de Winter JJ, Paramarta JE, et al. Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort StudyArthritis Rheumatol. 2016;68:2444\u20132455.","DOI":"10.1002\/art.39766"},{"key":"2026071309102994797_j_rir-2026-0025_ref_122","doi-asserted-by":"crossref","unstructured":"Ez-Zaitouni Z, Hilkens A, Gossec L,et al. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts. Arthritis Res Ther. 2017;19:118.","DOI":"10.1186\/s13075-017-1335-8"},{"key":"2026071309102994797_j_rir-2026-0025_ref_123","doi-asserted-by":"crossref","unstructured":"Braun J, Blanco R, Marzo-Ortega H, et al. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis. Arthritis Res Ther. 2023;25:80.","DOI":"10.1186\/s13075-023-03051-5"},{"key":"2026071309102994797_j_rir-2026-0025_ref_124","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Baraliakos X, Hermann KA, et al. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4\u2011year imaging outcomes from the RAPID\u2011axSpA phase III randomised trial. Ann Rheum Dis. 2018;77:699\u2013705.","DOI":"10.1136\/annrheumdis-2017-212377"},{"key":"2026071309102994797_j_rir-2026-0025_ref_125","doi-asserted-by":"crossref","unstructured":"Molto A, L\u00f3pez-Medina C, Sepriano A, et al. Sacroiliac radiographic progression over 10 years in axSpA: data from the DE-SIR inception cohort. Ann Rheum Dis. 2024;83:858\u2013864.","DOI":"10.1136\/ard-2023-225184"},{"key":"2026071309102994797_j_rir-2026-0025_ref_126","doi-asserted-by":"crossref","unstructured":"Sieper J, van der Heijde D, Dougados M, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis. 2013;72:815\u2013822.","DOI":"10.1136\/annrheumdis-2012-201766"},{"key":"2026071309102994797_j_rir-2026-0025_ref_127","doi-asserted-by":"crossref","unstructured":"Maksymowych W.P, Dougados M, van der Heijde D, et al. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Ann Rheum Dis. 2016;75:1328\u20131335.","DOI":"10.1136\/annrheumdis-2015-207596"},{"key":"2026071309102994797_j_rir-2026-0025_ref_128","doi-asserted-by":"crossref","unstructured":"Sieper J, van der Heijde D, Dougados M, et al. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2015;67:2702\u20132712.","DOI":"10.1002\/art.39257"},{"key":"2026071309102994797_j_rir-2026-0025_ref_129","doi-asserted-by":"crossref","unstructured":"Deodhar A, Reveille J.D, van den Bosch F, et al. The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration\u2019s comments and concerns. Arthritis Rheumatol. 2014;66:2649\u20132656.","DOI":"10.1002\/art.38776"},{"key":"2026071309102994797_j_rir-2026-0025_ref_130","doi-asserted-by":"crossref","unstructured":"Landew\u00e9 R, Braun J, Deodhar A, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a doubleblind randomised placebo-controlled Phase 3 study. Ann Rheum Dis. 2014;73:39\u201347.","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"2026071309102994797_j_rir-2026-0025_ref_131","doi-asserted-by":"crossref","unstructured":"Deodhar A, Blanco R, Dokoupilov\u00e1 E, et al. Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study Arthritis Rheumatol. 2021;73:110\u2013120.","DOI":"10.1002\/art.41477"},{"key":"2026071309102994797_j_rir-2026-0025_ref_132","unstructured":"Deodhar A, van der Heijde D, Gensler LS, et al. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial Lancet. 2020;395:53\u201364."},{"key":"2026071309102994797_j_rir-2026-0025_ref_133","doi-asserted-by":"crossref","unstructured":"Deodhar A, Van den Bosch F, Poddubnyy D, et al. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo controlled, phase 3 trial. Lancet. 2022;400:369\u2013379.","DOI":"10.1016\/S0140-6736(22)01212-0"},{"key":"2026071309102994797_j_rir-2026-0025_ref_134","doi-asserted-by":"crossref","unstructured":"Chandran V. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different? Curr Opin Rheumatol. 2019;31:329\u2013334.","DOI":"10.1097\/BOR.0000000000000609"},{"key":"2026071309102994797_j_rir-2026-0025_ref_135","doi-asserted-by":"crossref","unstructured":"Poddubnyy D, Axial psoriatic arthritis. An evolving concept. Rheum Dis Clin North Am. 2025;51:433\u2013445.","DOI":"10.1016\/j.rdc.2025.05.004"}],"container-title":["Rheumatology and Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0025\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:12:02Z","timestamp":1783933922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2026-0025\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":135,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,7,13]]}},"alternative-id":["10.1515\/rir-2026-0025"],"URL":"https:\/\/doi.org\/10.1515\/rir-2026-0025","relation":{},"ISSN":["2719-4523"],"issn-type":[{"value":"2719-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}